Clinical Trials Logo

Clinical Trial Summary

The purpose of this trial is to investigate the safety and effect of CaReS-1S to repair knee cartilage defects.


Clinical Trial Description

CaReSR-1S is a sterile, ready for use round implant based on a dense matrix of native Collagen type I. It is indicated for the defect filling of focal, full layer and clearly defined knee and ankle cartilage defects of longest diameter 1.1-2.2cm. The fixation of CaReSR-1S is made for all sizes with fibrin glue, whereas the 11 mm implants also allow a press-fit anchoring due to the elasticity of the implant.

The physical nature of the CaReSR-1S allows the in-growth of healthy chondrocytes, as well as progenitor cells from the surrounding healthy tissue. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03307668
Study type Interventional
Source Arthro-Anda Tianjin Biologic Technology Co., Ltd.
Contact Dong-xing Xie, PhD
Phone 86073189753006
Email 491703175@qq.com
Status Recruiting
Phase N/A
Start date January 1, 2014
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT05785949 - Chondro-Gide® Bilayer Collagen Membrane in Knee Cartilage Defect Repair N/A